DLD Asset Management’s ESSA Pharma EPIX Stock Holding History

DLD Asset Management’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-314,968	Closed	-$535K	–	370
2025 Q2	$535K	Buy	314,968 +131,310	+71%	+$222K	0.04%	151
2025 Q1	$290K	Buy	+183,658	New	+$311K	0.02%	112

Other funds holding EPIX

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

DLD Asset Management's EPIX Position: Q3 2025 in Review

DLD Asset Management sold out of ESSA Pharma (EPIX) in Q3 2025, closing a stake of 314,968 shares — an estimated $535K sold.

DLD Asset Management first reported a position in EPIX in Q1 2025 and held it in 2 quarters. The position peaked at $535K in Q2 2025. 32 funds tracked by Wall St. Rank hold EPIX as of Q3 2025.

DLD Asset Management reported no remaining ESSA Pharma position as of Q3 2025 after selling out during the quarter.
DLD Asset Management sold 314,968 ESSA Pharma shares in Q3 2025, an estimated $535K.
DLD Asset Management first reported a position in ESSA Pharma in Q1 2025 and held it in 2 quarters.
DLD Asset Management's ESSA Pharma position peaked at $535K in Q2 2025.
32 funds tracked by Wall St. Rank held ESSA Pharma as of Q3 2025.

Based on DLD Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.